-
EOFlow Initiates Eco-Friendly Disposal Campaign for EOPatch in Korea Embracing and Integrating Environmental, Social, and Governance (ESG)
▶EOFlow will collect, process, and dispose of used EOPatch pumps in an environmentally safe manner ▶EOFlow will set up an Incentive Program for this Campaign EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, announced today that the Company is initiating an environmentally friendly disposal campaign to minimize the impact of used EOPatch pumps on the environment. As there are no environmental regulations or guidelines for proper disposal of used medical devices in Korea, used patc...Nov. 09. 2021 -
EOFlow to Raise 100 Billion Korean Won and Offer Stock Split Capital Raised Will Be Used For Global Market Expansion
▶ 100 billion Won to be raised with new common stock offering, to be followed by a 2:1 stock split EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, has announced today that the Company will raise some 100 billion Won with new common stock offering, after which it will do a 2:1 stock split. The Company will make a new public offering of its common stocks. The company will issue up to 3,000,000 shares of common stocks, representing 25.99% of the current total number of issued shares. The...Oct. 28. 2021 -
EOFlow and Sinocare Establish a Joint Venture Company
▶ Sinocare is China’s Largest Diabetes Management Instrument Manufacturer ▶ Joint venture company to launch a full-scale effort for clinical study to obtain regulatory approval for EOPatch manufacturing and distribution in China ▶ High growth expected from EOPatch business in China where world’s largest diabetes population live EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, has announced today that the Company will establish a joint venture company “SINOFLOW Co., Ltd...Oct. 27. 2021 -
EOFlow Begins Clinical Study of its Wearable Insulin Pump “EOPatch” on People With Type 2 diabetes in Korea
▶ This clinical study involves ten leading university hospitals and up to one hundred and thirty-six people with Type 2 diabetes. It is Korea’s largest ever clinical study employing insulin pumps. ▶ This pioneering study aims to demonstrate and validate efficacy of EOPatch for Type 2 diabetes therapy. EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, has announced today that the Company completed enrollment of first patient in a clinical study on type 2 diabetes for its wearable in...Oct. 14. 2021 -
EOFlow Completes its First Shipment to Europe
▶ EOFlow’s European exclusive distributing partner Menarini to showcase the EOPatch at EASD 2021 EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, has made its first shipment to Europe today. After launching the wearable insulin pump in Korea this March and obtaining the CE certification in May, EOFlow is now expanding its reach to Europe, starting with the first shipment completed on September 30. EOFlow officially launched its EOPatch, Korea’s first (and the w...Sep. 30. 2021 -
EOFlow Officially Launches its First Wearable Insulin Pump “EOPatch”
▶ EOPatch resolves unmet needs in conventional insulin delivery and insulin pumps ▶ With its 3.5-day cycle, twice-a-week routine will improve compliance ▶ EOPatch will be available to all users through Huons from early April On March 29, EOFlow, a company specializing in wearable drug delivery solutions, announced that it officially launches its wearable insulin pump “EOPatch” in Korea, which is the first in Korea and the second in the world to be commercially available. EOPatch is a disposable wearable insulin pump which is...Mar. 29. 2021 -
EOPatch’s Smartphone Application 'Narsha' Gets Korean MFDS Approval
▶ World's first commercialized smartphone app to delivery insulin for wearable pump ▶ Satisfied the cyber security requirements from the Korean MFDS and market needs ▶ EOFlow's first wearable insulin pump, EOPatch will be fully launched in Korea on the 29th On March 24, EOFlow, a provider of wearable drug delivery solutions, has announced on the 24th that ‘Narsha,’ a smartphone application for wearable insulin delivery, obtained medical device approval from the Ministry of Food and Drug Safety (MFDS) on the 23rd. Nar...Mar. 24. 2021 -
EOFlow Announces Participation in the Korea International Medical & Hospital Equipment Show
EOFlow has announced that it is participating in the Korea International Medical & Hospital Equipment Show (KIMES 2021) held at COEX, Seoul Korea until the 21st. The company is showcasing the wearable insulin pump EOPatch. EOPatch is the world's second commercially produced disposable wearable insulin pump. Unlike other conventional insulin pumps, there is no infusion line. Once attached, insulin can be continuously injected for up to 3.5 days, maximizing user convenience. EOFlow's exhibition booth is accompanied by K-Bio H...Mar. 19. 2021 -
[NewsPim] EOFlow, Eager to Become the Next Big Wearable Medical Device Company
Jesse Kim, founding CEO of EOFlow had an interview with NewsPim reporter ahead of the launch of EOPatch. He emphasized that EOPatch can improve the quality of life for insulin users. EOPatch begins its full launch in Korea on March 29th. (in Korean only): http://www.newspim.com/news/view/20210317001119Mar. 19. 2021 -
[Hankyung BIO Insight] Insulin delivery and electrocardiogram (ECG) comes in wearable patches
Hankyung BIO Insight announced that Insulin delivery and electrocardiogram (ECG) is now available in wearable patches (in Korean only): https://www.hankyung.com/it/article/2021030304481Mar. 19. 2021 -
[Shinhan Investment] EOFlow, Much-anticipated schedule taking shape
EOFlow is sharing full English version of our recent analyst report from Shinhan Investment Corp. published on March 9th. It was written by two pharmaceutical/bio analysts DongGun Lee and JaeHee Won. Please refer to the attached file for the report and the article from Business Korea posted on March 10th. http://www.businesskorea.co.kr/news/articleView.html?idxno=62041 -EOPatch’s debut in Korean market on March 29 -EOPatch will be sold through the domestic partner Huons in online channel -EOFlow plans to ramp up sales...Mar. 11. 2021 -
[Shinhan Investment] Eoflow: Potential to Grow Bigger Than Insulet
EOFlow is sharing full English version of an analyst report from Shinhan Investment Corp. published on January 20th. The report is written by two pharmaceutical/bio analysts DongGun Lee and JaeHee Won. They commented that Eoflow is expected to launch EOPatch in the domestic market in 1Q21. They stated that the company plans to sell the flagship product through its domestic partner Huons, and apply for national health insurance coverage to accelerate market penetration. They stated that the CE marking to sell in Europe will likely be obta...Mar. 11. 2021 -
EOFlow Issues Convertible Bonds Worth 35 Billion Korean Won
EOFlow Issues Convertible Bonds Worth 35 Billion Korean Won... Raised Capital Will be Used on Clinical Trials, R&D and Investment in New Businesses ▶ EOFlow aims to develop clinical studies and R&D of wearable artificial pancreas (AP), develop R&D and investments in new wearable drug delivery solutions ▶ EOFlow secures mid- to long-term growth momentum based on the innovative EOPatch platform technology [2021-01-19] EOFlow, a provider of wearable drug delivery solutions, has announced that the company will issue convertib...Jan. 19. 2021 -
EOFlow to Present at the 39th Annual J.P. Morgan Healthcare Conference (JPM)
EOFlow, a provider of wearable drug delivery solutions, today announces that the company has been invited to the 39th Annual J.P. Morgan Healthcare Conference (JPM) to be held virtually during January 11 to 14, 2021. EOFlow plans to present its EOPatch, disposable wearable insulin pump system, and the company's digital healthcare capabilities at the event.Dec. 23. 2020 -
EOPatch on MBC News
EOPatch introduced as a future of wearable medical service in MBC's Sunday night news on 12/20/2020 (in Korean only): https://news.naver.com/main/tvgallery/replay.nhn?sid=370&fbclid=IwAR0IrIGgyrDcwC9OPXS1dW_6SQrTl8qYUJE4ptDfwZ2Wkb-ukRyM7GU-v0Y#214_0001087369Dec. 21. 2020
Healthcare Innovation Park #H2202 Dolma-ro 172 Bundang-gu Seongnam-si Gyeonggi-do Republic of Korea
T (+82) 031-738-0200
F (+82) 031-738-0208
COPYRIGHT ⓒ 2017 EOFLOW CO., LTD. All Rights Reserved.
